vs

Side-by-side financial comparison of Axalta Coating Systems Ltd. (AXTA) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

Axalta Coating Systems Ltd. is the larger business by last-quarter revenue ($5.1B vs $665.5M, roughly 7.7× Natera, Inc.). Natera, Inc. runs the higher net margin — 7.1% vs 1.8%, a 5.3% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs -0.6%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $21.0M). Over the past eight quarters, Axalta Coating Systems Ltd.'s revenue compounded faster (94.5% CAGR vs 34.5%).

Axalta Coating Systems Ltd., also known as simply Axalta, is an American company specializing in coatings in a wide variety of industrial applications, materials and sectors, including automotive paints. The company is based in Philadelphia, Pennsylvania, and incorporated in Bermuda. Axalta develops and manufactures coatings for light and commercial vehicles, industrial, and refinish applications. The firm does business in 130 countries, has nearly 13,000 employees, and has more than 100,000 ...

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

AXTA vs NTRA — Head-to-Head

Bigger by revenue
AXTA
AXTA
7.7× larger
AXTA
$5.1B
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+40.4% gap
NTRA
39.8%
-0.6%
AXTA
Higher net margin
NTRA
NTRA
5.3% more per $
NTRA
7.1%
1.8%
AXTA
More free cash flow
NTRA
NTRA
$16.8M more FCF
NTRA
$37.8M
$21.0M
AXTA
Faster 2-yr revenue CAGR
AXTA
AXTA
Annualised
AXTA
94.5%
34.5%
NTRA

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AXTA
AXTA
NTRA
NTRA
Revenue
$5.1B
$665.5M
Net Profit
$91.0M
$47.3M
Gross Margin
83.6%
Operating Margin
2.9%
-3.4%
Net Margin
1.8%
7.1%
Revenue YoY
-0.6%
39.8%
Net Profit YoY
-9.1%
187.9%
EPS (diluted)
$0.42
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXTA
AXTA
NTRA
NTRA
Q1 26
$5.1B
Q4 25
$1.3B
$665.5M
Q3 25
$1.3B
$592.2M
Q2 25
$1.3B
$546.6M
Q1 25
$1.3B
$501.8M
Q4 24
$1.3B
$476.1M
Q3 24
$1.3B
$439.8M
Q2 24
$1.4B
$413.4M
Net Profit
AXTA
AXTA
NTRA
NTRA
Q1 26
$91.0M
Q4 25
$60.0M
$47.3M
Q3 25
$110.0M
$-87.5M
Q2 25
$109.0M
$-100.9M
Q1 25
$99.0M
$-66.9M
Q4 24
$137.0M
$-53.8M
Q3 24
$101.0M
$-31.6M
Q2 24
$112.0M
$-37.5M
Gross Margin
AXTA
AXTA
NTRA
NTRA
Q1 26
83.6%
Q4 25
33.4%
Q3 25
34.9%
Q2 25
35.0%
Q1 25
34.3%
Q4 24
34.1%
Q3 24
35.0%
Q2 24
34.0%
Operating Margin
AXTA
AXTA
NTRA
NTRA
Q1 26
2.9%
Q4 25
12.8%
-3.4%
Q3 25
15.8%
-16.5%
Q2 25
14.8%
-20.2%
Q1 25
13.9%
-15.8%
Q4 24
14.3%
-13.6%
Q3 24
14.6%
-8.9%
Q2 24
15.2%
-10.6%
Net Margin
AXTA
AXTA
NTRA
NTRA
Q1 26
1.8%
Q4 25
4.8%
7.1%
Q3 25
8.5%
-14.8%
Q2 25
8.4%
-18.5%
Q1 25
7.8%
-13.3%
Q4 24
10.5%
-11.3%
Q3 24
7.7%
-7.2%
Q2 24
8.3%
-9.1%
EPS (diluted)
AXTA
AXTA
NTRA
NTRA
Q1 26
$0.42
Q4 25
$0.28
$0.36
Q3 25
$0.51
$-0.64
Q2 25
$0.50
$-0.74
Q1 25
$0.45
$-0.50
Q4 24
$0.63
$-0.41
Q3 24
$0.46
$-0.26
Q2 24
$0.51
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXTA
AXTA
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$608.0M
Total DebtLower is stronger
$3.1B
Stockholders' EquityBook value
$2.5B
$1.7B
Total Assets
$7.6B
$2.4B
Debt / EquityLower = less leverage
1.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXTA
AXTA
NTRA
NTRA
Q1 26
$608.0M
Q4 25
$657.0M
Q3 25
$606.0M
$1.0M
Q2 25
$625.0M
$16.0M
Q1 25
$575.0M
$17.8M
Q4 24
$593.0M
$22.7M
Q3 24
$567.0M
$29.5M
Q2 24
$840.0M
$90.3M
Total Debt
AXTA
AXTA
NTRA
NTRA
Q1 26
$3.1B
Q4 25
$3.2B
Q3 25
$3.4B
Q2 25
$3.4B
Q1 25
$3.4B
Q4 24
$3.4B
Q3 24
$3.5B
Q2 24
$3.6B
Stockholders' Equity
AXTA
AXTA
NTRA
NTRA
Q1 26
$2.5B
Q4 25
$2.3B
$1.7B
Q3 25
$2.3B
$1.3B
Q2 25
$2.3B
$1.2B
Q1 25
$2.1B
$1.2B
Q4 24
$1.9B
$1.2B
Q3 24
$1.9B
$878.5M
Q2 24
$1.8B
$836.5M
Total Assets
AXTA
AXTA
NTRA
NTRA
Q1 26
$7.6B
Q4 25
$7.6B
$2.4B
Q3 25
$7.8B
$1.8B
Q2 25
$7.8B
$1.8B
Q1 25
$7.4B
$1.7B
Q4 24
$7.2B
$1.7B
Q3 24
$7.5B
$1.6B
Q2 24
$7.3B
$1.5B
Debt / Equity
AXTA
AXTA
NTRA
NTRA
Q1 26
1.27×
Q4 25
1.36×
Q3 25
1.48×
Q2 25
1.50×
Q1 25
1.64×
Q4 24
1.78×
Q3 24
1.84×
Q2 24
2.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXTA
AXTA
NTRA
NTRA
Operating Cash FlowLast quarter
$73.9M
Free Cash FlowOCF − Capex
$21.0M
$37.8M
FCF MarginFCF / Revenue
0.4%
5.7%
Capex IntensityCapex / Revenue
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$491.0M
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXTA
AXTA
NTRA
NTRA
Q1 26
Q4 25
$344.0M
$73.9M
Q3 25
$137.0M
$59.4M
Q2 25
$142.0M
$37.6M
Q1 25
$26.0M
$44.5M
Q4 24
$234.0M
$52.9M
Q3 24
$194.0M
$51.8M
Q2 24
$114.0M
$4.0M
Free Cash Flow
AXTA
AXTA
NTRA
NTRA
Q1 26
$21.0M
Q4 25
$286.0M
$37.8M
Q3 25
$87.0M
$37.0M
Q2 25
$97.0M
$11.7M
Q1 25
$-17.0M
$22.6M
Q4 24
$172.0M
$34.8M
Q3 24
$161.0M
$35.5M
Q2 24
$91.0M
$-7.7M
FCF Margin
AXTA
AXTA
NTRA
NTRA
Q1 26
0.4%
Q4 25
22.7%
5.7%
Q3 25
6.8%
6.2%
Q2 25
7.4%
2.1%
Q1 25
-1.3%
4.5%
Q4 24
13.1%
7.3%
Q3 24
12.2%
8.1%
Q2 24
6.7%
-1.9%
Capex Intensity
AXTA
AXTA
NTRA
NTRA
Q1 26
Q4 25
4.6%
5.4%
Q3 25
3.9%
3.8%
Q2 25
3.4%
4.7%
Q1 25
3.4%
4.3%
Q4 24
4.7%
3.8%
Q3 24
2.5%
3.7%
Q2 24
1.7%
2.8%
Cash Conversion
AXTA
AXTA
NTRA
NTRA
Q1 26
Q4 25
5.73×
1.56×
Q3 25
1.25×
Q2 25
1.30×
Q1 25
0.26×
Q4 24
1.71×
Q3 24
1.92×
Q2 24
1.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons